Esperion Therapeutics reported $18.58M in Trade Creditors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Alnylam Pharmaceuticals ALNY:US USD 40.57M 11.85M
Amarin AMRN:US USD 93.16M 23.15M
Amgen AMGN:US USD 1.2B 52M
Biogen BIIB:US USD 383.2M 51.6M
Cytokinetics CYTK:US USD 14.43M 351K
Daiichi Sankyo 4568:JP JPY 332.22B 1.94B
Eli Lilly And LLY:US USD 1.68B 23.9M
Esperion Therapeutics ESPR:US USD 18.58M 5.75M
Halozyme Therapeutics HALO:US USD 18.17M 5.93M
Heron Therapeutics HRTX:US USD 6.55M 7.26M
Intercept Pharmaceuticals ICPT:US USD 21.3M 9.64M
Intra Cellular Therapies ITCI:US USD 14.22M 3.47M
IONIS PHARMACEUT IONS:US USD 20.54M 10.19M
Minerva Neurosciences NERV:US USD 533K 987K
Moderna Inc MRNA:US USD 330M 149M
Nektar Therapeutics NKTR:US USD 5.33M 7.02M
Ptc Therapeutics PTCT:US USD 20.86M 2.02M
Puma Biotechnology PBYI:US USD 14.93M 5.09M
Regeneron Pharmaceuticals REGN:US USD 535.6M 1.4M
Sarepta Therapeutics SRPT:US USD 118.46M 62.25M
Seattle Genetics SGEN:US USD 144.5M 15.63M
Vanda Pharmaceuticals VNDA:US USD 5.58M 36K